1. Home
  2. BTMD vs DMA Comparison

BTMD vs DMA Comparison

Compare BTMD & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.21

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Logo Destra Multi-Alternative Fund

DMA

Destra Multi-Alternative Fund

HOLD

Current Price

$7.46

Market Cap

76.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
DMA
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
76.4M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
BTMD
DMA
Price
$2.21
$7.46
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$2.83
N/A
AVG Volume (30 Days)
209.8K
33.9K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
722.22
N/A
EPS
0.06
N/A
Revenue
$192,219,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$39.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$6.94
52 Week High
$4.75
$9.15

Technical Indicators

Market Signals
Indicator
BTMD
DMA
Relative Strength Index (RSI) 54.83 51.15
Support Level $1.97 $7.27
Resistance Level $2.79 $8.88
Average True Range (ATR) 0.15 0.20
MACD 0.02 0.05
Stochastic Oscillator 58.72 65.71

Price Performance

Historical Comparison
BTMD
DMA

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.

Share on Social Networks: